INTRODUCTION
============

Azoospermia, identified up to 15% of infertile men, recognizes a possible cause in the blockage of the male reproductive tract \[[@B1]\]. Thus, it can be classified as obstructive azoospermia (OA), comprising 40% of all azoospermia cases and non-obstructive azoospermia (NOA) \[[@B2]\]. NOA is characterized by an intrinsic, often idiopathic, testicular impairment that negatively influences spermatogenic function. Usually, open surgical testicular sperm extraction techniques are preferred in these type of patients, even if minimally invasive approaches are available in literature \[[@B2]\]. OA is instead usually due to ductal obstruction anywhere like efferent ducts, rete testis, ejaculatory duct, vas deferens, and epididymis. In the majority of OA cases, spermatogenesis is not impaired, so that successful sperm retrieval (SSR) gets to 96% to 100%. In this scenario, microsurgical reconstruction might represent a safe and efficacious therapeutic option performing vasovasostomy or vasoepididymostomy when exists vasal or epidydimal obstruction, respectively. Alternatively, sperm retrieval techniques, such as testicular fine-needle aspiration (TEFNA), or testicular sperm aspiration (TESA) could be performed in order to obtain viable spermatozoa for *in vitro* fertilization/intracytoplasmic sperm injection (ICSI) purpose. In the assessment of azoospermic patients, TEFNA is considered effective as open biopsy, due to the high chances of sperm retrieval \[[@B3][@B4][@B5]\]. However, the quantity of testicular tissue picked is poor, depending by the method used. For this reason, previous authors described alternative techniques using larger needles \[[@B6][@B7]\] or 'biopty gun' \[[@B8]\], in order to improve the yield of testicular tissue, and to provide larger seminiferous tubules to the embryologist. Although the literature contains the technical details of TESA procedure, there is no general consensus on which is the best approach that allows to obtain higher SSR rates. Moreover, there is a lack of a comprehensive indication regarding to the type of azoospermia, sperm recovery rates, and specifically clinical circumstances.

The aim of this study was to describe our preliminary experience performing TEFNA with a larger needle in a case series of infertile patients with OA, and to perform a systematic review of the literature concerning the different testicular needle aspiration techniques.

MATERIALS AND METHODS
=====================

1. Study population
-------------------

Between March 2017 and June 2018, we prospectively recruited 30 consecutive azoospermic patients who referred to our Assisted Reproductive Technologies (ARTs) Center. After the couple had undergone a complete assessment including a female gynaecological evaluation, all men underwent further assessment of the cause of azoospermia, in order to select the more appropriate sperm retrieval technique. The diagnosis of OA was based on patient history, physical and genital examination, semen analysis, endocrinology profile and genetic studies. Patients\' data included information regarding age, weight and height, smoking and drinking habits, history of cryptorchidism, mumps orchitis, varicocele, environmental or radiation exposure, prescribed drug use, previous chemotherapy, or surgical procedures. All patients underwent genital examination and scrotal Doppler ultrasound scan to detect testicular volume and to exclude the presence of epididymis head or tail dilatation, unilateral or bilateral absence of vas deferens and varicocele \[[@B9]\]. A trans-rectal ultrasound Scan was performed to rule out the presence of prostate median cysts and of anomalies of the seminal vesicles suggestive of obstruction of the male genital tract \[[@B10]\]. Genetic assessment was performed, including karyotype, analysis of microdeletions for Y chromosome and mutations of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) genes. Hormonal profile was also documented during hospitalization prior to surgery in all patients. Normal levels of serum follicle-stimulating hormone (FSH), luteinizing hormone (LH), and total testosterone (TT) were considered respectively 1.5--8.0 IU/L, 1.8--12.0 IU/L, and 2.7--18.0 ng/mL. Prolactin levels were considered normal between 3.0 and 18 ng/mL and thyroid stimulating hormone (TSH) between 0.3 and 5.5 mIU/L.

2. Ethics statement
-------------------

All participants were adequately counselled and agreed to have their data anonymously utilized. Informed consent was submitted by all subjects when they were enrolled. The present study protocol was reviewed and approved by the Institutional Review Board (IRB) of University of Florence, Careggi Hospital (IRB No. CS/1158/07.1). All procedures were performed in accordance with the ethical standards of the institutional and national research committee and with the 1975 Helsinki Declaration.

3. Surgical technique
---------------------

All patients enrolled underwent a bilateral TEFNA. The procedure has been performed under short-acting analgo-sedation. The scrotal skin was cleaned with 10% Povidone-iodine solution and sterile draped. Each testis was immobilized manually putting the epididymis and vas deferens posteriorly, safe from injury. Testes was aspirated twice at three different sites, upper, middle and lower part, using a larger disposable 18-gauge butterfly needle with 60 mL Luer-Lock syringe attached to it ([Fig. 1](#F1){ref-type="fig"}). The needle was inserted into the testis to a depth of about 2 cm. Every testicular puncture was composed of multiple precise rapid in and out movements until the yellowish fluid aspirated ceased to flow or if bloody fluid appeared. The tubing was then occluded with an artery forceps, maintaining a negative pressure. Subsequently, removing very slowly the needle from the testis and scrotal skin, we extracted some intact seminiferous tubules, protruding from the site of puncture. This tissue was prudently cut with sharp scissors and placed in the Petri dishes, using two pairs of fine tweezers. Following each puncture, the contents was washed in a 15-mL centrifuge tube containing 1 mL of flushing medium, using a 20 mL syringe filled with Hams medium. Retrieved tissue was instantaneously brought to the adjacent embryology laboratory to rule out the presence of spermatozoa. An ice pack was applied on the scrotum following the procedure for twenty minutes.

On the same day of sperm retrieval, the female underwent an oocyte pick-up procedure after ovarian stimulation protocol, in order to perform an ICSI cycle by fresh gametes.

4. Embryological processing
---------------------------

Each sample was processed by centrifugation at 1,800 rpm for 7 minutes. The pellet was observed under inverted microscopy at ×200 for a first evaluation of the presence and motility of spermatozoa.

If retrieved, spermatozoa were either used fresh for an ICSI cycle or alternatively cryopreserved for later use, if the female was not responder to ovarian stimulation protocol. If the embryologist observed more than 1--2 sperms/field (corresponding to an estimated concentration of 0.001 ×10^6^ spermatozoa/mL), sperm retrieval was considered to be successful for use. For each patient the quantity and quality of sperm retrieved at the time of TEFNA was recorded, including mean sperm concentration, mean total sperm motility and mean number of bio system straws when sperm was cryopreserved.

5. Statistical analysis
-----------------------

Patient characteristics were described using medians and interquartile range (IQR) in the case of continuous variables and number and percentages for dichotomous variables. Student t-test and Mann-Whitney U-test were used to compare variables, including age and hormonal level. All collected data were evaluated with Statistical Package for Statistical Sciences (IBM SPSS ver. 22.0; IBM Co., Armonk, NY, USA).

6. Systematic literature review
-------------------------------

A systematic review of English-language literature was performed up to June 2018 in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA statement) criteria. The Medline, Scopus, Web of Science, and PubMed databases were screened separately by two different authors using a single query in order to identify the articles describing the possible techniques of TEFNA for sperm retrieval purpose in azoospermic patients. Conflicts were resolved by discussion or with an independent arbiter. The authors screened all the articles indexed in the aforementioned databases using the following query: (((((TEFNA) OR testicular fine needle aspiration) OR TESA) OR testicular sperm aspiration) OR sperm retrieval) AND azoospermia. Randomized clinical trials, retrospective, prospective, observational, and comparative studies on humans were included, while case reports and review were excluded. According to the predefined inclusion and exclusion criteria, title and abstracts were screened and articles categorized. After reading the abstract, a more thorough assessment was performed by looking at the full texts of the paper. References from the included studies were manually retrieved to identify additional studies of interest. A new excel table was built including data from the selected articles and including number of participants, interventions, comparators, outcomes, and study design (PICOS), as indicated by the Systematic Review Guidance of the Center for Reviews and Dissemination of the University of York (Center for Reviews and Dissemination. Guidance for undertaking reviews in health care. [www.york.ac.uk/crd/guidance](www.york.ac.uk/crd/guidance)). In addition, a data extraction form was developed in order to collect, for each study, relevant information on type of azoospermia, surgical technique details, type of anesthesia, intraoperative and postoperative complications, SSR, embryological outcomes, type of ART treatment (fresh ICSI or cryopreservation). The flow chart depicting the entire review process is shown in [Fig. 2](#F2){ref-type="fig"}.

7. Study endpoints
------------------

The main objectives of the study were: 1) to describe our preliminary experience using a larger needle by TEFNA in OA patients, making a small step toward the standardization of technique, 2) to provide a detailed overview of the available evidence on the different testicular needle aspiration techniques depicted in literature.

RESULTS
=======

1. Case series
--------------

All patients had a clinical presentation of absolute azoospermia in almost two semen analyses (according to the 2010 World Health Organization guidelines). The baseline characteristics of the study cohort (30 patients) are depicted in [Table 1](#T1){ref-type="table"}. Median age at the time of TEFNA was 40 years (IQR: 30--51 years). No patients suffered from any chronic medical diseases, such as diabetes or cardiovascular disease. In 20/30 cases, abnormalities in CFTR gene were detected, including the more common ΔF508 mutation and the rare mild mutations 2789+ 5G\>A, 2758+ 5G\>A, 2657+ 5G\>A. The 10/30 patients presented OA secondary to traumatic medullary lesion. All patients had a normal urine analysis with a negative urine-culture, as well as a negative semen culture test. Screening for sexually transmitted diseases was negative in all patients. The scrotal and trans-rectal ultrasounds documented a median testicular right volume of 18 mL (IQR: 12--25 mL) and a median left testicular volume of 18 mL (IQR: 12--25 mL). Congenital bilateral absence of the vas deferens (CBAVD) was showed in 16 patients, bilateral agenesis of seminal vesicles in 4 patients. At baseline, median FSH serum level was 4.4 IU/L (IQR: 2.8--10.0 IU/L), median LH serum level was 3.0 IU/L (IQR: 2.2--4.2 IU/L), and median TT levels were 4.5 ng/mL (IQR: 1.4--9.5 ng/mL). Prolactin and TSH levels were in the normal range in all patients. All men were diagnosed with OA.

Median operative time was 16 minutes (IQR: 12--30 minutes). No intraoperative complications occurred. The 2/30 patients (6.7%) reported postoperative adverse events at a median one-month follow-up: 1 patient had prolonged orchialgia for one week, 1 patient presented scrotal hematoma resolved spontaneously after few days. The overall SSR rate was 93.3% (28/30 patients). Median sperm concentration was 0.05 ×10^6^/mL (IQR: 0.001--0.1 ×10^6^/mL). Median total sperm motility was 10% (IQR: 0%--15%). In 20/30 men (66.7%) sperm retrieved was used for fresh ICSI cycle, in 8/30 (26.7%) sperm cryopreservation was necessary, because on the day of sperm retrieval the female resulted not responder to ovarian stimulation. In this cases median number of 3 (IQR: 1--4) bio system straws was cryopreserved.

2. Evidence synthesis
---------------------

### 1) Quality of the studies

Overall, 873 potentially relevant articles were detected. After duplicates removed, among a total of 866 studies 94 were assessed for eligibility and finally 34 articles were included in this systematic review. Ten articles presented a prospective study design with a small study cohort sample size \[[@B11][@B12][@B13][@B14][@B15][@B16][@B17][@B18][@B19][@B20][@B21]\]. [Fig. 2](#F2){ref-type="fig"} outlines the study selection process according to the PRISMA flow. [Table 2](#T2){ref-type="table"} provides the summary of all included studies.

### 2) Characteristics of study population

A total of 4,954 patients were recruited in this review. In 3,868 cases the type of azoospermia was specified. 2,343/3,868 patients (60.6%) had a clinical presentation of NOA, 1,525/3,868 had OA (39.4%). Of all, 4,376 men underwent testicular aspiration techniques for sperm retrieval, including TEFNA, TESA, and percutaneous testicular biopsy. Mean overall SSR rate was 74.2%±28.9% (range: 11%--100%). Mean sperm concentration and sperm motility were reported in few studies, ranging from 0.0005 ×10^6^/mL to 45 ×10^3^/mL, and 0% to 20%, respectively \[[@B11][@B13][@B20][@B22][@B23][@B24][@B25]\]. ART treatment planned included fresh ICSI or sperm cryopreservation.

### 3) Technical details

In most cases, the principal anaesthesiology approach was local anesthesia, including spermatic cord block \[[@B12][@B21][@B22][@B23][@B24][@B25][@B26][@B27][@B28][@B29][@B30][@B31][@B32]\]. Usually, this one was performed using 5--7 mL of 2% lidocaine injected with 23-gauge needle \[[@B33]\]. In other cases, general anesthesia can be performed to enable the operator to sample multiple regions of the testis, providing a very high likelihood of sperm retrieval for ICSI \[[@B11][@B12][@B13][@B15][@B34][@B35][@B36]\]. One author described the technique under epidural anesthesia \[[@B37]\].

Across all studies, gauge needle varied from 14- to 26-gauge. In the majority of studies describing the fineneedle aspiration (FNA) method, the needle employed ranged from 19- to 23-gauge. In few articles, some alternative techniques were detected, using larger disposable needles. In this cases, percutaneous aspiration biopsy using intravenous catheter 14- or 16-gauge or 'biopty gun' 14-gauge needle were described \[[@B11][@B28][@B30][@B38]\].

The number of testicular punctures that were performed ranged from a minimum of 1 \[[@B12][@B18][@B21][@B23][@B27][@B29][@B35][@B39]\] to a maximum of 15 \[[@B15]\] for each testis. Some authors preferred one single testicular puncture carried out in multiple directions (4--5) for each testis \[[@B12][@B23][@B27]\]. In no case, the operating time of the surgical procedure was collected.

### 4) Intraoperative and postoperative complications

In the majority of articles none intraoperative or postoperative complications were reported. Only few authors recorded testicular bleeding or hematocele intraoperatively \[[@B13][@B24][@B26][@B40]\]. Scrotal hematoma, superficial wound separation, spot adhesions or hematocele were the main postoperative adverse events described, even if their occurrence remains very low \[[@B5][@B19][@B22][@B23][@B24][@B25][@B26][@B29][@B31][@B41]\]. In some cases, spermatic cord hematoma occurred \[[@B31]\]. All these postoperative complications not required surgical interventions.

DISCUSSION
==========

The aspiration needle biopsy technique was originally described in 1930 for the diagnosis of palpable lesions \[[@B42]\]. Nowadays, it represents a widespread technique proposed for the exploration of many superficial organs, including thyroid nodule examination \[[@B43]\]. The application of testicular needle biopsy to andrology field finds a place in male infertility for ART purpose \[[@B2]\].

Testicular aspiration techniques (TEFNA, TESA) can be considered a relatively safe, effective, easy and inexpensive method for sperm recovery. Cost-effectiveness, simplicity and its minimal invasiveness are the main advantages, if compared with other procedures \[[@B44]\]. These mentioned surgical techniques can be applied both to NOA and OA patients; SSR rates are described excellent (96% to 100%) only in OA cases, while remain lower in secretive azoospermia (10% to 15%) \[[@B45]\]. According to this findings, the overall sperm retrieval rate by TEFNA or TESA has been reported different in literature, due to different surgical techniques adopted and study populations characteristics (i.e., type of azoospermia). Indeed, in the majority of the studies analysed in this review, the study population was represented by NOA patients (60%), contrary to it was expected \[[@B46][@B47][@B48]\]. The reason why this technique is widely used in NOA can be explained by the practice of a diagnostic purpose, planned before to perform a fresh ART treatment. Moreover, since our review comprised studies from two past decades, nowadays a diagnostic biopsy itself could be considered an obsolete procedure, not without possible risks \[[@B49]\]. On these bases, the SSR rate obtained in this systematic analysis, through percutaneous testicular aspiration techniques, proved to be higher (up to 100%) in patients with OA, avoiding the need to recur to open surgical techniques. Indeed, open surgical sperm retrieval methods nowadays still remain the gold standard for secretive azoospermia, since sperm retrieval could be unsuccessful in almost 50% of cases. In these patients, especially microdissection open surgical techniques are considered the more appropriate method, because of their higher successful rates \[[@B50]\].

Thus, on the basis of previous evidences, in NOA patients it would be recommended to perform firstly an open testicular sperm extraction procedure, avoiding all possible complications derived from testicular aspiration \[[@B9]\]. According to literature, among all the patients enrolled in our case series, the SSR rate was very high (93.3%). Indeed, all the men presented OA with marked predictive factors of positive sperm retrieval, as shown by testicular volume and serum FSH levels that were in the normal range. Nevertheless, it is known that OA patients may also have some damage in spermatogenesis, as result of the long-lasting obstruction causing impairment to the spermatogenic tubules \[[@B51]\].

Regarding technical details, when TEFNA or TESA was performed, needles of different sizes are generally employed, ranging from 18- to 23-gauge. Equally, the number of total testicular punctures varied considerably, achieving a maximum of 15 punctures for testis \[[@B15]\]. The need to use larger needles comes from the necessity to obtain more testicular tissue, in particular when a simultaneously oocyte retrieval was planned. Some authors described alternative methods, using intravenous catheter 14- or 16-gauge, in order to obtain more testicular parenchyma \[[@B26]\], or 18-gauge butterfly needle to examine the testis by histology \[[@B29][@B31][@B36]\]. Fahmy et al \[[@B26]\] described a new modification of needle aspiration biopsy, devoid of complications, simple, and inexpensive, using an ordinary intravenous catheter (14- or 16-gauge) to retrieve spermatozoa from patients with OA, comparing it to the classical FNA method. SSR rate appeared higher using an intravenous catheter compared to the standard FNA (98.1% vs. 51.6%, p\<0.05).

Also an innovative technique using a 'biopty gun' with 14-gauge needle, was developed by Hovatta et al \[[@B25]\] in cases of OA, concluding that the method used may make open scrotal operations obsolete. In several studies, TEFNA performed with relatively large needles, such as 19-gauge, reduced the necessity of open surgical biopsy \[[@B12][@B22][@B27]\], ranging high chances of sperm retrieval. On the other hand, the use of a smaller 26-gauge needle, as described by Dajani et al \[[@B5]\], provides low likelihood of sperm retrieval (SSR=14.8%).

Therefore, on the basis of the available literature and confirmed by the results of this systematic review, no standardized needle for testicular aspiration exists. In this scenario, we preferred to use a larger needle (18-gauge) in order to ensure a very high likelihood to retrieve spermatozoa for fresh ICSI treatment. [Table 3](#T3){ref-type="table"} summarized the variables of our case series compared to literature.

Regarding anaesthesiology approach, the type of anaesthesia employed during the procedure differs widely, but in most cases it is local, including the spermatic cord block or short-acting sedation. However, in order to perform more testicular punctures, a general anaesthesia could be preferred, as shown by Lewin et al \[[@B38]\]. Only one author performed the procedure utilizing an epidural anaesthesia \[[@B37]\]. In our case series, we preferred a short acting analgo-sedation, based on the short operative timing and postop recovery that allow us a rapid patient discharge.

Moreover, the needles used for TEFNA could not be large enough to allow cryopreservation of the tissue fragment. However, as shown in literature, the ability to cryopreserved spermatozoa not depends by the gauge needle utilized, but by the total number of punctures and consequently by the quantity of tissue picked. These evidences are confirmed also by our series, in which testicular aspirations allowed sperm cryopreservation when the female resulted not responder to ovarian stimulation.

As demonstrated by previous studies applied in the field of palpable thyroid nodules, large needle aspiration biopsy could be associated with less tissue injury than large needle cutting biopsy \[[@B43]\].

Nevertheless, in this systematic review, intra-operative and postoperative complication rates not differ considerably using different size of needles. In fact, scrotal hematoma occurred using a larger 'biopty gun' 14-gauge needle, as well as the smaller 26-gauge needle. 3 cases of inguinal nerve pain were described by Makhseed et al \[[@B14]\] using 21-gauge needle. In no case surgical interventions were necessary to repair haematocele postoperatively. Few cases of testicular bleeding and 3 cases of vasovagal syncope during the procedure under local anaesthesia were recorded \[[@B31]\]. Overall, in our reports, the absence of intraoperative complications and the low number of postoperative adverse events could be attributed to the choice of performing only three fine needle punctures in each testis and using ice packs following the procedure.

Regarding embryological outcomes, the majority of the studies reviewed not specified total sperm concentration and motility, but focused on the ART outcomes. The large variability in terms of sperm concentration and motility probably may depend by several factors, including the number and site of testicular punctures, and the size of the needle. In our experience, the use of 18-gauge needle enabled the embryologist to process up to 0.1 ×10^6^/mL spermatozoa, with up a 15% of motility. Obtaining more motile and viable spermatozoa, could be in our opinion a key point, in order to increase the likelihood of successful ART outcomes, in terms of fertilization and cleavage rates.

Nevertheless, the current study had some limitations. The main weakness of our series is represented by the small number of the study cohort, moreover, limited to OA patients. Although SSR rate was very high (93.3%) using a larger needle 18-gauge, we need a larger comparative studies to implement the application of this technique in clinical practice. Another possible limit of this study could be the absence of long term follow-up of postop complications (hematomas, fibrosis or development of antisperm antibodies) \[[@B52]\]. Moreover, the ICSI outcomes, including fertilization, cleavage and pregnancy rates were not recorded. On these premises, future prospective studies will be addressed to clarify what type of azoospermia benefits from this procedure, and if a larger needle permits to obtain both higher sperm concentration and more sperm motility and viability, in order to improve the overall pregnancy rate. Furthermore, future studies investigating all possible predicting factors of SSR are recommendable, with the purpose to optimize the choice of treatment.

This is the first systematic review that analyses the technical details of testicular aspiration techniques, in particular the gauge needle employed and the number of punctures performed.

The studies included in this review have several limitations including inhomogeneity with regard to study design, quality of reporting and standardization of technical surgical details. Most studies included in our review are retrospective and did not define either standardized selection criteria for the choice of a specific needle to use or the more appropriate number of testicular punctures.

CONCLUSIONS
===========

The use of larger needles in minimally invasive testicular aspiration techniques provides to obtain more tissue, increasing the chancing of SSR, in particular when fresh ICSI cycle was planned. In our experience, the procedure using the 18-gauge needle applied twice at three different testis sites proved to be feasible, safe and effective for ART treatment. Our systematic review highlights the current lack of general consensus on the ideal study population (type of azoospermia) and on the more appropriate technical aspects (type of gauge needle, number of punctures, type of anaesthesia). For this reasons, future comparative prospective studies are mandatory to evaluate the best indication and the real contribution of TESA procedures, and to standardized this surgical technique for ART purpose.
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###### Baseline characteristic of the study cohort

![](wjmh-37-55-i001)

  Parameter                         Value
  --------------------------------- -------------------
  Age (y) (male)                    40 (30--51)
  BMI (kg/m^2^)                     25 (18--30)
  Smoker                            8 (26.7)
  Alcohol use                       12 (40.0)
  CFTR mutations                    20 (66.7)
  Chromosomal anomalies             0 (0)
  Right TV (mL)                     18 (12--25)
  Left TV (mL)                      18 (12--25)
  FSH (IU/L)                        4.4 (2.8--10.0)
  LH (IU/L)                         3.0 (2.2--4.2)
  TT (ng/mL)                        4.5 (1.4--9.5)
  PRL (ng/mL)                       8.5 (3.2--9.0)
  TSH (mIU/L)                       3.1 (2.2--5.5)
  SSR                               28 (93.3)
  Sperm concentration (×10^6^/mL)   0.05 (0.001--0.1)
  Total sperm motility (%)          10 (0--15)
  Straws cryopreserved              3 (1--4)

Values are presented as median (interquartile range) or number (%). BMI: body mass index, CFTR: Cystic Fibrosis Transmembrane Conductance Regulator, TV: testicular volume, FSH: follicle stimulating hormone, LH: luteinizing hormone, TT: total testosterone, PRL: prolactin, TSH: thyroid stimulating hormone, SSR: successful sperm retrieval.

###### Characteristics of study population and surgical technique details obtained from included studies (n=34)

![](wjmh-37-55-i002)

  First author (year)                  Study design    No. of total patient   No. of NOA patient   No. of OA patient   No. of TEFNA/TESA patient   Needle (G)               No. of punctures                Operating time   Anaesthesia                                    SSR (%)         ART treatment                  Sperm concentration (mean)   Sperm motility (mean)   Intraoperative complications                              Postoperative complications
  ------------------------------------ --------------- ---------------------- -------------------- ------------------- --------------------------- ------------------------ ------------------------------- ---------------- ---------------------------------------------- --------------- ------------------------------ ---------------------------- ----------------------- --------------------------------------------------------- -------------------------------------------------------------------
  An (2018) \[[@B37]\]                 Retrospective   324                    150                  174                 174                         NA                       NA                              NA               Epidural                                       100             Cryopreservation, fresh ICSI   NA                           Not specified           NA                                                        NA
  Jensen (2016) \[[@B31]\]             Retrospective   208                    125                  82                  208                         18                       Multiple needle pass            NA               Spermatic cord block, local                    100             NA                             NA                           NA                      3/267 3 cases of vasovagal syncope during the procedure   Scrotal hematoma, spermatic cord hematoma
  Roque (2015) \[[@B29]\]              Retrospective   97                     97                   0                   97                          18                       1×testis                        NA               Spermatic cord block, local                    44              Cryopreservation               NA                           NA                      None                                                      Hematoma
  Alrabeeah (2014) \[[@B30]\]          Retrospective   54                     54                   0                   54                          16                       3×testis                        NA               Spermatic cord block, local                    94              NA                             NA                           NA                      NA                                                        NA
  Nowroozi (2012) \[[@B25]\]           Retrospective   450                    450                  0                   385                         23                       NA                              NA               Spermatic cord block, local                    41.8            NA                             NA                           NA                      NA                                                        NA
  Semião-Francisco (2010) \[[@B32]\]   Retrospective   376                    102                  274                 376                         21                       4×testis                        NA               Spermatic cord block, local                    100             NA                             NA                           NA                      NA                                                        NA
  Borges (2010) \[[@B21]\]             Prospective     296                    211                  85                  296                         21                       1×testis                        NA               Spermatic cord block, local                    89.1            NA                             NA                           NA                      NA                                                        NA
  Shefi (2009) \[[@B18]\]              Retrospective   56                     56                   0                   56                          23                       4×testis                        NA               Local                                          39              NA                             NA                           NA                      NA                                                        NA
  Houwen (2008) \[[@B47]\]             Retrospective   350                    350                  0                   281                         19                       5--10×testis                    NA               Local                                          45.9            NA                             NA                           NA                      NA                                                        NA
  Goulis (2008) \[[@B17]\]             Prospective     51                     34                   17                  51                          23                       4×testis                        NA               Local                                          41              NA                             NA                           NA                      NA                                                        NA
  Sereni (2008) \[[@B20]\]             Prospective     15                     1                    14                  15                          23                       NA                              NA               Local                                          Not specified   Cryopreservation               NA                           13.7                    NA                                                        NA
  Garg (2008) \[[@B40]\]               Retrospective   40                     0                    40                  40                          19                       NA                              NA               Local                                          97              Cryopreservation               NA                           NA                      Hematoma                                                  None
  El-Haggar (2008) \[[@B19]\]          Prospective     100                    100                  0                   100                         23                       6--9×testis                     NA               Local                                          54              NA                             NA                           NA                      None                                                      Hematoma, hematocele bruises of scrotal skin at the puncture site
  Hauser (2006) \[[@B36]\]             NA              87                     87                   0                   87                          18                       3×testis                        NA               General                                        2.3             NA                             NA                           3                       NA                                                        NA
  Pasqualotto (2005) \[[@B48]\]        Retrospective   212                    84                   128                 84                          21                       NA                              NA               NA                                             67.6            Fresh ICSI                     NA                           NA                      NA                                                        NA
  Fahmy (2004) \[[@B26]\]              Retrospective   86                     0                    86                  86                          21--23                   2--3×testis                     NA               Spermatic cord block, local                    87.5            Fresh ICSI, cryopreservation   NA                           NA                      Testicular bleeding                                       Haematocele
  14--16                                                                                                                                                                                                                                                                                                                                                                                                                                  
  Levine (2003) \[[@B22]\]             Retrospective   220                    117                  103                 74                          19                       NA                              NA               Spermatic cord block, local                    86.4            Fresh ICSI, cryopreservation   21.6 ×10^6^                  19                      None                                                      Sub capsular hematoma
  Khadra (2003) \[[@B34]\]             Retrospective   84                     84                   0                   84                          22                       NA                              NA               General                                        53.6            NA                             NA                           NA                      None                                                      None
  Makhseed (2002) \[[@B14]\]           Prospective     15                     9                    6                   15                          21                       NA                              NA               Local                                          86.6            Fresh ICSI, cryopreservation   NA                           NA                      None                                                      Skin inflammation, inguinal nerve pain
  Lindheim (2001) \[[@B28]\]           Retrospective   10                     4                    6                   12                          14                       NA                              NA               Spermatic cord block                           100             Fresh ICSI, cryopreservation   NA                           NA                      None                                                      None
  Westlander (2001) \[[@B35]\]         Retrospective   56                     34                   22                  141                         19--21                   1--5×testis                     NA               General, local                                 99.2            Fresh ICSI, cryopreservation   NA                           NA                      None                                                      None
  Lewin (1999) \[[@B15]\]              Prospective     85                     NA                   NA                  85                          23                       15×testis                       NA               General                                        58.8            Fresh ICSI                     Variable                     NA                      None                                                      None
  Westlander (1999) \[[@B16]\]         Prospective     137                    86                   51                  137                         19--21                   5--6×testis                     NA               General, local                                 53.2            Fresh ICSI, cryopreservation   NA                           NA                      None                                                      None
  Sheynkin (1998) \[[@B11]\]           Prospective     9                      0                    9                   9                           22--14 (PercBiopsy)      1×testis                        NA               General or local                               67              NA                             0.009 ×10^6^                 0                       None                                                      None
  100                                                                                                                                                                                                                                                                                                                                                                                                                                     
  Ezeh (1998) \[[@B12]\]               Prospective     35                     35                   0                   35                          19                       1×testis (in 5 directions)      NA               Generalspermatic cord block                    14.2            Cryopreservation, fresh ICSI   NA                           NA                      None                                                      None
  Belker (1998) \[[@B23]\]             NA              179                    0                    179                 179                         20                       1×testis (in 4--5 directions)   NA               Local, spermatic cord block, brief general     62              Fresh ICSI                     0--45×10^3^                  0--20                   None                                                      Hematocele
  95                                                                                                                                                                                                                                                                                                                                                                                                                                      
  Dajani (1998) \[[@B5]\]              NA              1,000                  NA                   NA                  1,000                       26                       3×testis                        NA               Short-acting                                   14.8            NA                             NA                           NA                      NA                                                        Tiny hematomas, spot adhesions
  Levine (1998) \[[@B27]\]             NA              32                     0                    32                  32                          19--21                   1×testis (in different areas)   NA               Sedation and local with spermatic cord block   62.5            Fresh ICSI                     0.0005--120×10^6^            NA                      None                                                      None
  Rosenlund (1998) \[[@B46]\]          NA              22                     22                   0                   22                          19--21                   2--4×testis                     NA               Local                                          40              NA                             NA                           NA                      None                                                      None
  Tournaye (1998) \[[@B39]\]           NA              102                    0                    102                 51                          21                       1×testis                        NA               Local                                          100             NA                             0.0022×10^6^                 NA                      NA                                                        NA
  Friedler (1997) \[[@B13]\]           Prospective     37                     37                   0                   37                          21                       6×testis                        NA               General                                        11              Fresh ICSI                     Few                          NA                      Testicular bleeding                                       NA
  Turek (1997) \[[@B24]\]              NA              16                     14                   2                   16                          23                       ≥4×testis                       NA               Spermatic cord block                           37.5            NA                             NA                           NA                      Haematocele                                               Superficial wound separation
  Watkins (1997) \[[@B41]\]            Retrospective   80                     0                    80                  40                          20                       2--3×testis                     NA               Local                                          100             Fresh ICSI                     NA                           NA                      NA                                                        Scrotal hematoma
  Hovatta (1995) \[[@B38]\]            NA              33                     0                    33                  17                          14 (biopty gun needle)   NA                              NA               Local                                          82.3            Fresh ICSI                     0.42 ×10^6^                  8.3                     NA                                                        Scrotal hematoma

NOA: non-obstructive azoospermia, OA: obstructive azoospermia, TEFNA: testicular fine-needle aspiration, TESA: testicular sperm aspiration, SSR: successful sperm retrieval, ART: Assisted Reproductive Technology, NA: not available, ICSI: intracytoplasmic sperm injection.

###### Mean variables of our case series compared to literature

![](wjmh-37-55-i003)

  Variable                            Case series                    Literature review
  ----------------------------------- ------------------------------ ---------------------------------------
  Gauge needle (mean)                 18                             19.97
  No. of punctures (×testis) (mean)   3                              3.56
  SSR (%)                             93.9                           74.26
  Anaesthesia type                    Local, general, epidural       Short-acting
  Intraoperative complications type   None                           Bleeding, hematocele
  Postoperative complications type    Orchialgia, hematoma           Hematoma, spot adhesions, haematocele
  ART treatment type                  Cryopreservation, fresh ICSI   Cryopreservation, fresh ICSI

SSR: successful sperm retrieval, ART: Assisted Reproductive Technology, ICSI: intracytoplasmic sperm injection.

[^1]: ^\*^These authors contributed equally to this work as co-first authors.
